Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-059535
Filing Date
2025-04-29
Accepted
2025-04-29 06:06:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A korro_defa14a_2025.htm DEFA14A 32276
2 GRAPHIC img161143922_0.jpg GRAPHIC 1205180
3 GRAPHIC img161143922_1.jpg GRAPHIC 409668
  Complete submission text file 0000950170-25-059535.txt   2257472
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39062 | Film No.: 25882482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)